Drug profile · INN
romiplostim
NPLATE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
romiplostim (NPLATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN romiplostim
Brand NPLATE
Route SUBCUTANEOUS
Formulation INJECTABLE
ATC code B02BX04
Frequently asked questions
What is romiplostim?
romiplostim (NPLATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for romiplostim?
NPLATE is a marketed brand name for romiplostim. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of romiplostim?
romiplostim has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.